Servaas Michielssens, ESG, SRI

Pharma tariffs: a complex puzzle

On Sunday, July 27, 2025, the EU and the US successfully concluded a trade agreement, paving the way for strengthened economic relations between the two regions. While initial reports caused some confusion, it now appears that most pharmaceutical products, excluding certain generics, will be subject to a 15% tariff.
Coffee Break

Coffee Break - Powell’s Moment of Truth

The United States and the European Union have reached a trade deal that introduces a 15% blanket tariff on all EU goods imported into the US, along with additional EU commitments to purchase US energy and defense products. The agreement takes effect on Friday.
Coffee Break

Coffee Break - The pulse of the global economy

Flash PMIs for the US, euro zone, UK, and Japan will reveal July’s global economic momentum in manufacturing and services. These data points will influence central bank expectations and investor risk appetite across regions.
Research Paper, ESG, SRI, Marie Niemczyk, Jorick Liebrand

AI Through the ESG Lens: Tackling Risks and Opportunities

Is the Artificial Intelligence (AI) revolution unstoppable? With lightning speed, AI is reshaping industries, unlocking economic value, driving positive environmental impact, helping address social challenges – and additionally, offering compelling investment opportunities.
Monthly Coffee Break, Alternative Investments

Dancing on the ceiling*

As Lionel Richie put it in his 1980’s hit, “What is happening here? Something’s going on that’s not quite clear.”
Monthly Coffee Break, Equities

Investors shifting towards US technology stocks

After a sustained period of outperformance versus other regions, European equity markets have underperformed in recent weeks. This shift was marked by a notable rotation into US technology stocks during the month of June.

Find it fast

Get information faster with a single click

Get insights straight to your inbox